A Study of LY3463251 in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The purpose of this study is to evaluate the safety and tolerability (side effects) of single (Part A) and multiple (Part B) doses of the study drug when it is administered subcutaneously (under the skin) into the abdomen. This is a two‐part study. Participants will enroll in only one part. For each participant, Part A will last about 10 weeks and Part B will last about 13 weeks, including screening.
Epistemonikos ID: 58d246932f35bfd83824157714ee3984acc21914
First added on: May 21, 2024